<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY alias="ena-PROJECT-RPI-10-12-2012-15:39:06:512-4" center_name="RPI" accession="ERP007559">
    <IDENTIFIERS>
      <PRIMARY_ID>ERP007559</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject">PRJEB1191</EXTERNAL_ID>
      <SUBMITTER_ID namespace="RPI">ena-PROJECT-RPI-10-12-2012-15:39:06:512-4</SUBMITTER_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Draft Genome Sequence of Escherichia coli Strain ATCC #23502 (serovar O5:K4(L):H4)</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Whole Genome Sequencing"/>
      <STUDY_ABSTRACT>We report the 4.682-Mbp high-quality draft assembly of the Escherichia coli strain ATCC #23502 (serovar O5:K4(L):H4, also known as NCDC U1-41) genome. This uropathogenic strain is produces a glycosaminoglycan-like capsular polysaccharide with a backbone similar in structure to unsulfated chondroitin, a precursor to the nutraceutically and potentially pharmaceutically valuable compound chondroitin sulfate. Metabolic reconstruction of this genome will enable prediction of gene engineering strategies leading to increased chondroitin production.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>Escherichia coli K4</CENTER_PROJECT_NAME>
      <STUDY_DESCRIPTION>We report the 4.682-Mbp high-quality draft assembly of the Escherichia coli strain ATCC #23502 (serovar O5:K4(L):H4, also known as NCDC U1-41) genome. This uropathogenic strain is produces a glycosaminoglycan-like capsular polysaccharide with a backbone similar in structure to unsulfated chondroitin, a precursor to the nutraceutically and potentially pharmaceutically valuable compound chondroitin sulfate. Metabolic reconstruction of this genome will enable prediction of gene engineering strategies leading to increased chondroitin production.</STUDY_DESCRIPTION>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
